Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.

Published Date: 15 Jan 2024

A dose of 70 Gy divided into 15 fractions demonstrated a good balance between safety and effectiveness in a small trial.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group

2.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

3.

Breast cancer-related fatigue: The benefits of adapted physical activity

4.

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

5.

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot